{"schemaVersion":"peptidescanner-evidence-bundle/v1","canonicalUrl":"https://peptidescanner.com/evidence/v1/peptides/apraglutide.json","manifestUrl":"https://peptidescanner.com/evidence/v1/manifest.json","peptide":{"slug":"apraglutide","name":"Apraglutide","url":"https://peptidescanner.com/peptides/apraglutide/"},"addressing":"objects is keyed by objectPathId. A URL fragment #<objectPathId> on this file names one evidence object. Every version of a record is placed in the bundle of the record's current first peptide.","objectCount":8,"objects":{"clinicaltrials-gov-nct04627025-apraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct04627025-apraglutide:v1","objectPathId":"clinicaltrials-gov-nct04627025-apraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04627025-apraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/apraglutide.json#clinicaltrials-gov-nct04627025-apraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/apraglutide.md#clinicaltrials-gov-nct04627025-apraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct04627025-apraglutide","version":1,"domain":"Clinical trials","dateInSource":"2024-11-27","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["apraglutide"],"peptides":[{"slug":"apraglutide","url":"https://peptidescanner.com/peptides/apraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT04627025","sourceIds":["ctg-observation-nct04627025-2024-11-27-33862c3edfc1"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT04627025 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-11-27, and PeptideScanner's reviewed identity mapping was apraglutide.","sourceIds":["ctg-observation-nct04627025-2024-11-27-33862c3edfc1"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT04627025 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-11-27, and PeptideScanner's reviewed identity mapping was apraglutide.","sourceIds":["ctg-observation-nct04627025-2024-11-27-33862c3edfc1"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct04627025-2024-11-27-33862c3edfc1"]}],"sources":[{"id":"ctg-observation-nct04627025-2024-11-27-33862c3edfc1","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT04627025 · retained source version 2024-11-27:33862c3edfc1d142d183d19484af2a0576a306288f110a84f44d6dec45422596","url":"https://clinicaltrials.gov/study/NCT04627025"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"092321c005ab2832fb30df3617252dcc7c6e9466c05a037fee302a5d3d13e12f","tierARecordSha256":"ac5e7b4c88d989776ae88c2d351bcb55d26726e7bdfdd068de9c9800fa06dd17"},"integrity":{"algorithm":"sha256","contentSha256":"d9e0b47103cd2b27c2991fbbf0cc2c671d97698ab302c7f66d11732ca204bda5"}},"clinicaltrials-gov-nct04699032-apraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct04699032-apraglutide:v1","objectPathId":"clinicaltrials-gov-nct04699032-apraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04699032-apraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/apraglutide.json#clinicaltrials-gov-nct04699032-apraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/apraglutide.md#clinicaltrials-gov-nct04699032-apraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct04699032-apraglutide","version":1,"domain":"Clinical trials","dateInSource":"2024-10-26","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["apraglutide"],"peptides":[{"slug":"apraglutide","url":"https://peptidescanner.com/peptides/apraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT04699032","sourceIds":["ctg-observation-nct04699032-2024-10-26-630253818817"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT04699032 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-10-26, and PeptideScanner's reviewed identity mapping was apraglutide.","sourceIds":["ctg-observation-nct04699032-2024-10-26-630253818817"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT04699032 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-10-26, and PeptideScanner's reviewed identity mapping was apraglutide.","sourceIds":["ctg-observation-nct04699032-2024-10-26-630253818817"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct04699032-2024-10-26-630253818817"]}],"sources":[{"id":"ctg-observation-nct04699032-2024-10-26-630253818817","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT04699032 · retained source version 2024-10-26:6302538188175ec900236f873275253b70f3e00a3e5139b54c94fed7f630ed5d","url":"https://clinicaltrials.gov/study/NCT04699032"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"cb497f6c66bf8bd0240711d3170c024dee57b76687d3188b6442fdb0ffe0f442","tierARecordSha256":"209c32fae57d88057735b8dc04bf532b997a843380786c61555c2cd60c6e95aa"},"integrity":{"algorithm":"sha256","contentSha256":"b7bfbf5c4c34c23b1d2c30fa739289d6ea779653bd48b7c3650ecdfd5dae7d5c"}},"clinicaltrials-gov-nct04964986-apraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct04964986-apraglutide:v1","objectPathId":"clinicaltrials-gov-nct04964986-apraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04964986-apraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/apraglutide.json#clinicaltrials-gov-nct04964986-apraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/apraglutide.md#clinicaltrials-gov-nct04964986-apraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct04964986-apraglutide","version":1,"domain":"Clinical trials","dateInSource":"2025-06-18","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["apraglutide"],"peptides":[{"slug":"apraglutide","url":"https://peptidescanner.com/peptides/apraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT04964986","sourceIds":["ctg-observation-nct04964986-2025-06-18-0f19bafdb5c9"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT04964986 at 2026-11-16T01:47:19.543Z. Its registry update date was 2025-06-18, and PeptideScanner's reviewed identity mapping was apraglutide.","sourceIds":["ctg-observation-nct04964986-2025-06-18-0f19bafdb5c9"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT04964986 at 2026-11-16T01:47:19.543Z. Its registry update date was 2025-06-18, and PeptideScanner's reviewed identity mapping was apraglutide.","sourceIds":["ctg-observation-nct04964986-2025-06-18-0f19bafdb5c9"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct04964986-2025-06-18-0f19bafdb5c9"]}],"sources":[{"id":"ctg-observation-nct04964986-2025-06-18-0f19bafdb5c9","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT04964986 · retained source version 2025-06-18:0f19bafdb5c9e2355f6aa64060d01b77ba5a45f44584e890f7f3f8e932df50c5","url":"https://clinicaltrials.gov/study/NCT04964986"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"614dc8eb929289c22ed1f52793237b2e22446cf6531e52906366a3a27b78ca65","tierARecordSha256":"1c94ced76d8d536a1815b42323720d4ebdf32c53733e10ebae58f67d79dc3321"},"integrity":{"algorithm":"sha256","contentSha256":"1e91566139cc15e7934a797086b73a3d3101f147a066c4c764c0f40ffe2b462c"}},"clinicaltrials-gov-nct05018286-apraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct05018286-apraglutide:v1","objectPathId":"clinicaltrials-gov-nct05018286-apraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05018286-apraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/apraglutide.json#clinicaltrials-gov-nct05018286-apraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/apraglutide.md#clinicaltrials-gov-nct05018286-apraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct05018286-apraglutide","version":1,"domain":"Clinical trials","dateInSource":"2025-07-02","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["apraglutide"],"peptides":[{"slug":"apraglutide","url":"https://peptidescanner.com/peptides/apraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT05018286","sourceIds":["ctg-observation-nct05018286-2025-07-02-f176ac852b48"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT05018286 at 2026-11-16T01:47:19.543Z. Its registry update date was 2025-07-02, and PeptideScanner's reviewed identity mapping was apraglutide.","sourceIds":["ctg-observation-nct05018286-2025-07-02-f176ac852b48"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT05018286 at 2026-11-16T01:47:19.543Z. Its registry update date was 2025-07-02, and PeptideScanner's reviewed identity mapping was apraglutide.","sourceIds":["ctg-observation-nct05018286-2025-07-02-f176ac852b48"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct05018286-2025-07-02-f176ac852b48"]}],"sources":[{"id":"ctg-observation-nct05018286-2025-07-02-f176ac852b48","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT05018286 · retained source version 2025-07-02:f176ac852b4898df9697babe58bebd3233457b165dcc9034e8a6cd5b55388c8c","url":"https://clinicaltrials.gov/study/NCT05018286"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1099bf80e4cd1bc9a181339150ad5ccd35cfadb5306c37e62c857cd7e5481fc4","tierARecordSha256":"aea079dfb409e19253cdd3be33c4e1b320a842a37598cf1cf40ca17a68ca134c"},"integrity":{"algorithm":"sha256","contentSha256":"ee5898a99f69d68a92188cd3829479e782590d3fb8a5e47faaaf4173a2c345dc"}},"clinicaltrials-gov-nct05706623-apraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct05706623-apraglutide:v1","objectPathId":"clinicaltrials-gov-nct05706623-apraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05706623-apraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/apraglutide.json#clinicaltrials-gov-nct05706623-apraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/apraglutide.md#clinicaltrials-gov-nct05706623-apraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct05706623-apraglutide","version":1,"domain":"Clinical trials","dateInSource":"2025-07-10","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["apraglutide"],"peptides":[{"slug":"apraglutide","url":"https://peptidescanner.com/peptides/apraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT05706623","sourceIds":["ctg-observation-nct05706623-2025-07-10-de7774cd90ae"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT05706623 at 2026-11-16T01:47:19.543Z. Its registry update date was 2025-07-10, and PeptideScanner's reviewed identity mapping was apraglutide.","sourceIds":["ctg-observation-nct05706623-2025-07-10-de7774cd90ae"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT05706623 at 2026-11-16T01:47:19.543Z. Its registry update date was 2025-07-10, and PeptideScanner's reviewed identity mapping was apraglutide.","sourceIds":["ctg-observation-nct05706623-2025-07-10-de7774cd90ae"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct05706623-2025-07-10-de7774cd90ae"]}],"sources":[{"id":"ctg-observation-nct05706623-2025-07-10-de7774cd90ae","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT05706623 · retained source version 2025-07-10:de7774cd90aed967f50268c2a2a452a1356e47651dd9c7cb5d2e40ae875b2c15","url":"https://clinicaltrials.gov/study/NCT05706623"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1f5be5df4b8d7b22928394c517d5dfc9e0dfd083f75b5d94a0f5aa7e642d7139","tierARecordSha256":"e34c52e607bf94193c8ca788abaffa8b594d8f88882552e051853fe20bde8679"},"integrity":{"algorithm":"sha256","contentSha256":"621aea9070d8e91cc9609a9aa4977fe88ef8c40783e2e4853bdf14864a294ce9"}},"clinicaltrials-gov-nct05995704-apraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct05995704-apraglutide:v1","objectPathId":"clinicaltrials-gov-nct05995704-apraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05995704-apraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/apraglutide.json#clinicaltrials-gov-nct05995704-apraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/apraglutide.md#clinicaltrials-gov-nct05995704-apraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct05995704-apraglutide","version":1,"domain":"Clinical trials","dateInSource":"2024-10-24","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["apraglutide"],"peptides":[{"slug":"apraglutide","url":"https://peptidescanner.com/peptides/apraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT05995704","sourceIds":["ctg-observation-nct05995704-2024-10-24-e60a3e5bc0b9"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT05995704 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-10-24, and PeptideScanner's reviewed identity mapping was apraglutide.","sourceIds":["ctg-observation-nct05995704-2024-10-24-e60a3e5bc0b9"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT05995704 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-10-24, and PeptideScanner's reviewed identity mapping was apraglutide.","sourceIds":["ctg-observation-nct05995704-2024-10-24-e60a3e5bc0b9"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct05995704-2024-10-24-e60a3e5bc0b9"]}],"sources":[{"id":"ctg-observation-nct05995704-2024-10-24-e60a3e5bc0b9","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT05995704 · retained source version 2024-10-24:e60a3e5bc0b9d57b7161bd3896366456523c48b9c5e0fe222774340bfcf9eb4b","url":"https://clinicaltrials.gov/study/NCT05995704"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"e637d5329c1437eb8d9ce92cb341612a903ca3519d0dfc804376d5bd387d5523","tierARecordSha256":"037ffd41b40a93caebc7cb242ad99919d0867340bd1753f9df797cc26167c675"},"integrity":{"algorithm":"sha256","contentSha256":"4837b3c597a7457be0ad12c2eeeae3972b46d63d8e175a6bad276d256ec30995"}},"clinicaltrials-gov-nct06002555-apraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06002555-apraglutide:v1","objectPathId":"clinicaltrials-gov-nct06002555-apraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06002555-apraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/apraglutide.json#clinicaltrials-gov-nct06002555-apraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/apraglutide.md#clinicaltrials-gov-nct06002555-apraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct06002555-apraglutide","version":1,"domain":"Clinical trials","dateInSource":"2024-10-26","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["apraglutide"],"peptides":[{"slug":"apraglutide","url":"https://peptidescanner.com/peptides/apraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06002555","sourceIds":["ctg-observation-nct06002555-2024-10-26-9f56c914ab5f"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06002555 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-10-26, and PeptideScanner's reviewed identity mapping was apraglutide.","sourceIds":["ctg-observation-nct06002555-2024-10-26-9f56c914ab5f"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06002555 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-10-26, and PeptideScanner's reviewed identity mapping was apraglutide.","sourceIds":["ctg-observation-nct06002555-2024-10-26-9f56c914ab5f"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06002555-2024-10-26-9f56c914ab5f"]}],"sources":[{"id":"ctg-observation-nct06002555-2024-10-26-9f56c914ab5f","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06002555 · retained source version 2024-10-26:9f56c914ab5fa3140a55576759f3bb1da291468f4fc2ed7d23fe0e3b86a09936","url":"https://clinicaltrials.gov/study/NCT06002555"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"3957c63fa907bd2af95edce4183fd425090da76f121c6788a5e426c15c927928","tierARecordSha256":"6093963e719c17ad07ad6fcbe7c793bdf5f3dc2ff4923cb6702ebd2ccd1f4d4a"},"integrity":{"algorithm":"sha256","contentSha256":"033788de0f8990f4d322ca3cee48eda5062a255ecfee7b6fb78bdb9889fefdd5"}},"clinicaltrials-gov-nct07742735-apraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07742735-apraglutide:v1","objectPathId":"clinicaltrials-gov-nct07742735-apraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07742735-apraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/apraglutide.json#clinicaltrials-gov-nct07742735-apraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/apraglutide.md#clinicaltrials-gov-nct07742735-apraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct07742735-apraglutide","version":1,"domain":"Clinical trials","dateInSource":"2026-08-04","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["apraglutide"],"peptides":[{"slug":"apraglutide","url":"https://peptidescanner.com/peptides/apraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07742735","sourceIds":["ctg-observation-nct07742735-2026-08-04-4023f7314739"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07742735 at 2026-11-16T01:47:19.543Z. Its registry update date was 2026-08-04, and PeptideScanner's reviewed identity mapping was apraglutide.","sourceIds":["ctg-observation-nct07742735-2026-08-04-4023f7314739"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07742735 at 2026-11-16T01:47:19.543Z. Its registry update date was 2026-08-04, and PeptideScanner's reviewed identity mapping was apraglutide.","sourceIds":["ctg-observation-nct07742735-2026-08-04-4023f7314739"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07742735-2026-08-04-4023f7314739"]}],"sources":[{"id":"ctg-observation-nct07742735-2026-08-04-4023f7314739","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07742735 · retained source version 2026-08-04:4023f7314739caea80157c1523434645be32b32a965d3d0f20c7c1b5dcdb3218","url":"https://clinicaltrials.gov/study/NCT07742735"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"846f8b52735ba21feda17dcde3795322a3ebddb3e21c92508a5c359f35184491","tierARecordSha256":"decf1b1eb11c7dba5fa0e9298b3ce39e96edfb6df3fb501b89f7bf9c9dd0e94f"},"integrity":{"algorithm":"sha256","contentSha256":"918ec1fdfa7f1bfe9d1feb99dc2c98387c39e42d5bd2b150414b601862a81fe5"}}}}
